What is Cogent Biosciences, Inc. Common Stock's Market Cap?

Cogent Biosciences, Inc. Common Stock's Market Cap is $6.1B, based on as-reported figures from SEC (XBRL) filings.

What is Cogent Biosciences, Inc. Common Stock's Enterprise Value?

Cogent Biosciences, Inc. Common Stock's Enterprise Value is $6.2B, based on as-reported figures from SEC (XBRL) filings.

What is Cogent Biosciences, Inc. Common Stock's EV / EBITDA?

Cogent Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Cogent Biosciences, Inc. Common Stock's Net Income (TTM)?

Cogent Biosciences, Inc. Common Stock's Net Income (TTM) is -$377.2M, based on as-reported figures from SEC (XBRL) filings.

What is Cogent Biosciences, Inc. Common Stock's EBITDA?

Cogent Biosciences, Inc. Common Stock's EBITDA is -$386.4M, based on as-reported figures from SEC (XBRL) filings.

What is Cogent Biosciences, Inc. Common Stock's Diluted EPS (TTM)?

Cogent Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.17, based on as-reported figures from SEC (XBRL) filings.

What is Cogent Biosciences, Inc. Common Stock's Net Debt?

Cogent Biosciences, Inc. Common Stock's Net Debt is $42.3M, based on as-reported figures from SEC (XBRL) filings.

Cogent Biosciences, Inc. Common Stock (COGT) Financial Statements

Cogent Biosciences, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG007DHY102

XNAS · usd

35.28▲ 0.52 (1.50%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close34.76

Day's Range33.90 – 35.75

52-Week Range11.60 – 43.73

Volume2.2M

Avg Volume1.7M

Share Statistics

Shares Outstanding

Employees258

ExchangeXNAS

Listed2018-03-29

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Cogent Biosciences, Inc. Common Stock (COGT)

What is Cogent Biosciences, Inc. Common Stock's Market Cap?: Cogent Biosciences, Inc. Common Stock's Market Cap is $6.1B, based on as-reported figures from SEC (XBRL) filings.
What is Cogent Biosciences, Inc. Common Stock's Enterprise Value?: Cogent Biosciences, Inc. Common Stock's Enterprise Value is $6.2B, based on as-reported figures from SEC (XBRL) filings.
What is Cogent Biosciences, Inc. Common Stock's EV / EBITDA?: Cogent Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cogent Biosciences, Inc. Common Stock's Net Income (TTM)?: Cogent Biosciences, Inc. Common Stock's Net Income (TTM) is -$377.2M, based on as-reported figures from SEC (XBRL) filings.
What is Cogent Biosciences, Inc. Common Stock's EBITDA?: Cogent Biosciences, Inc. Common Stock's EBITDA is -$386.4M, based on as-reported figures from SEC (XBRL) filings.
What is Cogent Biosciences, Inc. Common Stock's Diluted EPS (TTM)?: Cogent Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.17, based on as-reported figures from SEC (XBRL) filings.
What is Cogent Biosciences, Inc. Common Stock's Net Debt?: Cogent Biosciences, Inc. Common Stock's Net Debt is $42.3M, based on as-reported figures from SEC (XBRL) filings.